Sigma Planning’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Sigma Planning's TVTX Position: Q3 2026 in Review
Sigma Planning opened a new position in Travere Therapeutics (TVTX) in Q3 2026: 35,090 shares worth $2.07M. The stake represents 0.05% of the portfolio and ranks #338 among its holdings.
251 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Sigma Planning held 35,090 shares of Travere Therapeutics worth $2.07M as of Q3 2026.
- Travere Therapeutics was a new Sigma Planning position in Q3 2026.
- Travere Therapeutics made up 0.05% of Sigma Planning's portfolio in Q3 2026, its #338 holding.
- 251 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Sigma Planning's 13F filing for Q3 2026, filed 23 Oct 2026.